Blackstone and TPG Seek Over $4B for Hologic Unit Sale
Private equity giants Blackstone and TPG are reportedly pursuing a sale of a Hologic business unit valued at more than $4 billion.
Blackstone and TPG are jointly seeking buyers for a unit of medical technology company Hologic in a deal that could exceed $4 billion, according to reports. The move signals renewed appetite among large private equity firms for major healthcare asset divestitures as dealmaking activity picks up in 2025.
Hologic, best known for its women's health diagnostics and surgical products, has attracted private equity interest across several of its business segments in recent years. A transaction of this scale would rank among the larger healthcare buyouts attempted this year, underscoring how aggressively firms like Blackstone and TPG are deploying capital and recycling portfolio assets.
Read more Luxshare Raises $3.1B in Hong Kong's Largest IPO of 2025 →
Blackstone remains one of the world's largest alternative asset managers, while TPG has built a significant presence in healthcare-focused private equity. Their reported collaboration on a single asset of this magnitude reflects a broader trend of club deals returning to favor as buyers seek to spread risk on high-value transactions in an uncertain interest-rate environment.
The outcome of any sale process could draw interest from strategic acquirers in the medtech space as well as competing financial sponsors looking to gain exposure to healthcare diagnostics and related segments. No timeline or confirmed buyer has been publicly identified at this stage.
Continue reading at SeekingAlpha.
